YIELD10 BIOSCIENCE, INC. COMMO
Reported by Vigilant Capital Management LLC
First reported at 4,000 shares this quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2023-06-30 | 9000 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2023 | New | 4,000 | +4,000 (0.0%) | < 0.01% | $9,000 | 2023-08-08 |
Who else reported the position
16 managers reported YIELD10 BIOSCIENCE, INC. COMMO for Q2 2023.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Cannell & Co | Unchanged | 258,838 | 0 | 0.02% | $574,620 | 14 qtrs |
| ARMISTICE CAPITAL LLC | New | 216,000 | +216,000 | < 0.01% | $479,520 | 1 qtr |
| VANGUARD GROUP INC | Unchanged | 106,878 | 0 | < 0.01% | $237,269 | 10 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Unchanged | 34,857 | 0 | < 0.01% | $77,382 | 10 qtrs |
| BlackRock Inc | Unchanged | 31,380 | 0 | < 0.01% | $69,664 | 14 qtrs |
| Tower Research Capital LLC TRC | Added | 4,915 | +2,270 | < 0.01% | $10,911 | 12 qtrs |
| Vigilant Capital Management LLC This report | New | 4,000 | +4,000 | < 0.01% | $9,000 | 1 qtr |
| Concord Wealth Partners | Unchanged | 3,500 | 0 | < 0.01% | $7,770 | 6 qtrs |
| FMR LLC | New | 1,405 | +1,405 | < 0.01% | $3,119 | 1 qtr |
| WELLS FARGO & COMPANY MN | Added | 35 | +7 | < 0.01% | $78 | 14 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2023
- Filed
- August 08, 2023
- Filing type
- 13F-HR
- Position type
- COMMON STOCK
Voting authority reported
- Sole
- 4,000
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.